Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare... see more

Bullboard (NDAQ:INM)

View:
Post by Bullknit101on Jul 29, 2021 8:27am

Efficacious Agility

https://norml.org/blog/2021/07/28/revised-for-2021-norml-report-highlights-over-450-studies-assessing-the-therapeutic-efficacy-of-cannabis-and-cannabinoids/
Post by Bullknit101on Jul 28, 2021 10:44pm

Biomedican Patent

https://www.prnewswire.com/news-releases/biomedican-receives-approval-notification-from-the-us-patent-office-on-its-1st-patent-301342394.html
Post by Bullknit101on Jul 28, 2021 10:39pm

Market

https://www.businessinsider.com/biotechs-racing-to-capture-115-billion-market-for-synthetic-cannabis-2021-7
Post by Bullknit101on Jul 28, 2021 8:02pm

Microcap Biotechs

https://vistapglobal.com/daily_recap/fomc-stays-pat-as-smallcaps-microcaps-biotech-rip-vpwatchlists-atos-fate-inm-inmb-invo-higher/
Post by Bullknit101on Jul 28, 2021 4:21pm

European Cannabis Sector

Will Europe lead the way with cannabinoid medicine? https://www.forbes.com/sites/dylankennett1/2021/07/28/venture-capital-seizes-investment-opportunities-in-european-cannabis-sector/
Post by Bullknit101on Jul 27, 2021 11:42am

Cannabinoid Biosynthesis Report

https://www.edisongroup.com/investment-themes/biosynthesis-taking-the-cannabinoid-market-to-new-heights/
Post by Bullknit101on Jul 26, 2021 9:52am

UK Cannabinoids

https://www.politics.co.uk/comment/2021/07/26/how-the-uk-can-become-a-legal-cannabinoid-powerhouse/
Post by Bullknit101on Jul 25, 2021 1:14pm

Cannabinoid Medicine

https://www.theguardian.com/society/2021/jul/24/is-medical-cannabis-really-a-magic-bullet
Post by Bullknit101on Jul 23, 2021 6:44am

Rare Cannabinoids Value

https://www.pharmacytimes.com/view/expert-the-future-of-products-containing-rare-cannabinoids-is-in-pharmacy
Comment by Bullknit101on Jul 20, 2021 6:07pm

RE:Roth Capital Report

https://mobile.twitter.com/vistapresearch/status/1417514339481788430
Comment by Bullknit101on Jul 20, 2021 4:19pm

RE:RE:Rebound After Hours

Agreed, 131 shares is likely not smart money lol.
Post by Bullknit101on Jul 20, 2021 4:18pm

Roth Capital Report

On July 9th, Roth Capital Partners' Senior Research Analyst & Head of Pharmaceuticals Research, Scott Henry, CFA, issued an update report on InMed Pharma $INM with a BUY Rating titled, INM ...more  
Comment by Steveminon Jul 20, 2021 9:40am

RE:Rebound After Hours

So, smart money buys at 18% higher price to close with volume of 131 shares? Uh, no......
Post by Bullknit101on Jul 20, 2021 7:43am

Willow Biosciences News

https://www.newswire.ca/news-releases/willow-biosciences-announces-expansion-of-its-commercial-operations-team-and-development-portfolio-an-update-on-its-intellectual-property-position-and-formation ...more  
Post by Bullknit101on Jul 19, 2021 10:04pm

Rebound After Hours

A lot Cannabis and related sector investors got pommeled today. Thankfully, fundamentals will prevail in most cases. InMed is up over 18% after hours, so the smart money might be behind that. https ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities